Partial Restoration of Microbiomes for C-Section Infants

This article originally appeared here.
Share this content:
Partial Restoration of Microbiomes for C-Section Infants
Partial Restoration of Microbiomes for C-Section Infants

MONDAY, Feb. 1, 2016 (HealthDay News) -- Exposure to maternal vaginal fluids at birth can partially restore vaginal microbiomes for cesarean section-born infants, according to a study published online Feb. 1 in Nature Medicine.

Noting that infants delivered by cesarean section acquire a distinct microbiota from vaginally-delivered infants, Maria G. Dominguez-Bello, Ph.D., from New York University in New York City, and colleagues conducted a pilot study to expose infants delivered by cesarean section to maternal vaginal fluids at birth.

The researchers found that infants delivered by cesarean section and exposed to maternal vaginal fluids had gut, oral, and skin bacterial communities during the first 30 days of life that were enriched in vaginal bacteria, similar to vaginally-delivered babies; these bacteria were underrepresented in unexposed cesarean section-delivered infants. Oral and skin samples had greater microbiome similarity to those of vaginally-delivered infants than in anal samples.

"Although the long-term health consequences of restoring the microbiota of cesarean section-delivered infants remain unclear, our results demonstrate that vaginal microbes can be partially restored at birth in cesarean section-delivered babies," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »